| Gleason score | ||||||
---|---|---|---|---|---|---|---|
 | Benign | Insignificant prostate cancer | Clinically significant prostate cancer | ||||
 | Count | % | Count | % | Count | % | |
PIRADS score based on T2 and diffusion sequences only (biparametric) | 1 + 2 | 8 | 80.0 | 2 | 20.0 | 0 | 0.0 |
3 | 20 | 54.1 | 10 | 27.0 | 7 | 18.9 | |
4 | 0 | 0.0 | 3 | 30.0 | 7 | 70.0 | |
5 | 0 | 0.0 | 4 | 21.1 | 15 | 78.9 | |
PIRADS score (multiparametric) | 1 + 2 | 8 | 80.0 | 2 | 20.0 | 0 | 0.0 |
3 | 18 | 66.7 | 5 | 18.5 | 4 | 14.8 | |
4 | 2 | 10.0 | 8 | 40.0 | 10 | 50.0 | |
5 | 0 | 0.0 | 4 | 21.1 | 15 | 78.9 |